From protocol to publication: real-world evidence with method
Our Evidence Generation & Impact team runs Real-World Evidence studies end to end, integrating healthcare knowledge, data science and engineering to support decisions by industry, payers and health systems.
Services for RWD/RWE programs — from standardization to evidence
One partner to standardize data, generate evidence and deploy secure RWD/RWE environments.
End-to-end RWE studies
Protocol → analysis → CSR, manuscripts, abstracts and reports. OMOP or non-OMOP; includes OMOP CDM mapping/conversion and Data Partner engagement when needed.
Data Partner OMOP CDM conversion
Conversion of partner databases into standardized, reusable OMOP assets for RWD/RWE programs — with DQD and mapped vocabularies.
RWE + OMOP training
Custom 1-week course: 5 classes × 2h on OMOP, federated RWE studies and OHDSI best practices for data science teams.
RWD market analysis consulting
Consultative projects using RWD databases for market access, commercial, epidemiology and strategic objectives — market sizing, patient journey and lines of therapy.
VBHC contract auditing
Secure federated provider data flow to audit clinical indicators in value-based healthcare contracts.
Precision Data Platform
Where we run our studies, OMOP conversions and governed data sharing. Available as Standard, Enterprise and Data Partner.
Discover the platform8 steps from data to evidence
Beyond auditable and reproducible results, the Precision Evidence methodology relies on a federated infrastructure that is secure, agile and highly governed at the same time. Every step has a clear owner.
Protocol + Project Order
Study definition and scope: question, design, outcomes, period and population.
Precision DataScan Report
White Rabbit + inventory of the partner database: tables, fields, cardinalities and local vocabularies.
Data PartnerSynthetic DB + mappings
Vocabularies, annotations and ETL package developed on synthetic data — no access to real data.
Precision DataOMOP CDM database
ETL execution and CDM load inside the partner's environment.
Data PartnerSemantic layer
Semantic package for analysis: governed cohorts, metrics and dimensions.
Precision DataSemantic API
Deployment for governed access — only aggregates cross the federation.
Data PartnerDataset + TLF
Analytical extraction and outputs: tables, listings and figures.
Precision DataCSR / Evidence
RWE study report, manuscripts, abstracts and presentations.
Precision DataLatin American databases with high population representativeness
From DATASUS and ANS to private Data Partner databases, curated and standardized for multicenter studies in the region.
Brazil
DATASUS — SIH (inpatient), SIA (outpatient), SIM (mortality), SINAN (surveillance), CIHA (private). ANS — TISS inpatient and outpatient. Nexus — proprietary SIH + SIA linkage database, 8M+ patients, 2012–2025. Hapvida — EMR, claims and labs for 8M+ patients (private Data Partner).
Mexico
Egresos Hospitalarios — hospitalization database. Defunciones — mortality database.
Colombia
RIPS — individual health service provision records covering the whole country. Defunciones — mortality.
Chile
Egresos Hospitalarios — hospitalizations. GRD — DRG health records management system.
Epidemiology, pharmacoeconomics and data engineering on the same team
Physicians, PhDs in epidemiology, data architects and market access specialists — the combination that makes us unique in the LATAM market.
- Leading Scientist with a PhD in Infectious Disease Epidemiology (LSHTM) and 80+ published papers
- Data architecture with a master's in pharmacoeconomics: cost-effectiveness and budget impact models
- Founder recognized as a reference in health data science and OMOP CDM in Brazil
- Project management with Market Access and evidence-for-decision experience
Featured publications and awards
Nexus: deterministic linkage for longitudinal SUS data
A framework to build longitudinal real-world data from Brazil's SUS, with cohort profile and pharmacoepidemiology applications.
Read the paper
Early effects of HPV vaccination in Brazil
Interrupted time series on SIA/SUS data assess the quadrivalent vaccine's impact on high-grade cervical lesions.
Read the paper
Best scientific work — Clinical Application
Patient outcomes after ERCP with reprocessed duodenoscopes: award-winning oral presentation at the leading global RWE event.
See the showcaseHave a research question?
Tell us the outcome, the population and the market. We come back with a study design, the most suitable databases and a timeline.